LIQUIDIA
Live / Allowed — Notice of allowance issued (as of 22 Jul 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 11 Sept 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98977395
- Mark type
- Design + words
- Filed
- 11 Sept 2024
- Published for opposition
- 27 May 2025
- Attorney of record
- Devon E. White
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for treatment of respiratory diseases, namely, pharmaceuticals in the form of capsules comprised of microparticles and nanoparticles composed of polymers, excipients, therapeutics, and biologics; Pharmaceuticals for treatment of respiratory diseases, namely, pharmaceuticals in the nature of microparticles and nanoparticles with prophylactic properties composed of polymers, excipients, therapeutics, and biologics;
Owner
- Liquidia Technologies, Inc., Morrisville, NC, US
- Liquidia Technologies, Inc., Morrisville, NC, US
Prior registrations
Prosecution history
- 12 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Jul 2025 — USE AMENDMENT FILED
- 12 Jan 2026 — DIVISIONAL PROCESSING COMPLETE
- 24 Jul 2025 — DIVISIONAL REQUEST RECEIVED
- 12 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Jul 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 24 Jul 2025 — TEAS STATEMENT OF USE RECEIVED
- 22 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 May 2025 — PUBLISHED FOR OPPOSITION
- 21 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Apr 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED